BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/1/2021 3:51:08 AM | Browse: 33 | Download: 33
Publication Name World Journal of Clinical Cases
Manuscript ID 59705
Country/Territory China
Received
2020-09-23 14:05
Peer-Review Started
2020-09-23 14:06
To Make the First Decision
Return for Revision
2020-12-14 01:37
Revised
2020-12-26 13:23
Second Decision
2021-01-06 10:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-01-06 16:45
Articles in Press
2021-01-06 16:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-01-20 23:57
Typeset the Manuscript
2021-02-24 02:26
Publish the Manuscript Online
2021-03-01 03:51
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Metastatic thymic-enteric adenocarcinoma type responding to chemoradiation plus anti-angiogenic therapy: A case report
Manuscript Source Unsolicited Manuscript
All Author List Man Li, Xiao-Yu Pu, Li-Hua Dong and Peng-Yu Chang
ORCID
Author(s) ORCID Number
Man Li http://orcid.org/0000-0002-9876-0125
Xiao-Yu Pu http://orcid.org/0000-0001-9138-1598
Li-Hua Dong http://orcid.org/0000-0002-5148-2949
Peng-Yu Chang http://orcid.org/0000-0001-9047-7942
Funding Agency and Grant Number
Corresponding Author Li-Hua Dong, PhD, Chief Physician, Department of Radiation Oncology, The First Hospital of Jilin University, No. 71, Xinmin Street, Changchun 130021, Jilin , China. drlhdong@163.com
Key Words Radiotherapy; Chemotherapy; Case report; Thymic adenocarcinoma; Anti-angiogenic therapy; Thymic-enteric adenocarcinoma type
Core Tip This report introduces the diagnosis and treatment of a metastatic thymic-enteric adenocarcinoma type with positive expression of CDX2 and CK20. For the first time, radiotherapy and chemotherapy combined with anti-angiogenesis therapy were used. The tumor was partially remitted, and there was no sign of recurrence. XELOX (capecitabine plus oxaliplatin) combined with radiotherapy is an alternative treatment of inoperable metastatic thymic-enteric adenocarcinoma.
Publish Date 2021-03-01 03:51
Citation Li M, Pu X, Dong L, Chang P. Metastatic thymic-enteric adenocarcinoma type responding to chemoradiation plus anti-angiogenic therapy: A case report. World J Clin Cases 2021; 9(7): 1676-1681
URL https://www.wjgnet.com/2307-8960/full/v9/i7/1676.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i7.1676
Full Article (PDF) WJCC-9-1676.pdf
Full Article (Word) WJCC-9-1676.docx
Manuscript File 59705_Auto_Edited_WangTQ.docx
Answering Reviewers 59705-Answering reviewers.pdf
Audio Core Tip 59705-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 59705-Conflict-of-interest statement.pdf
Copyright License Agreement 59705-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 59705-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 59705-Language certificate.pdf
Peer-review Report 59705-Peer-review(s).pdf
Scientific Misconduct Check 59705-Bing-Yan JP-1.png
Scientific Misconduct Check 59705-Scientific misconduct check.pdf
Scientific Editor Work List 59705-Scientific editor work list.pdf